Calculate your body mass index (BMI)




Your BMI

Back to list

High Cholesterol Male Patients 243965

Study Dates: 14/11/19 - 25/1/20

Trial Number



●  Smoking (Yes)
●  Smoking (No)
●  Cholesterol


Up to: $3,920


Male, Smoker, Non-Smoker



Additional Information

You will need to attend three screening visits for this study, each of which you will be compensated for.

We are recruiting patients who are taking either Atorvastatin or Rosuvastatin. Other medications and ailments, such as diabetes, are permissible on this study.

The study consists of a nine night stay in our unit followed by eight outpatient visits. The total duration of the study from admission to final visit is 71 days.

Light smokers of five or less cigarettes (or the nicotine equivalent) per day, as well as non-smokers, are welcome to screen for this study.

The start dates for the study at the moment are shown below:

-Cohort 4a - Admission 18th November 2019

-Cohort 4b - Admission 25th November 2019

-Cohort 4c - Admission 2nd December 2019

-Cohort 4d - Admission 9th December 2019

Please call recruitment on 01895 614 888 for more information.


The Study drug is being developed to treat patients who suffer from hypercholesterolemia, more commonly known as high cholesterol.

This trial is looking to determine,

The safety and tolerability of the drug in humans.

How it is distributed, broken down and excreted from the body.

The effect of the drug on blood cholesterol levels.

The drug will be administered as a subcutaneous injection. A single, or several, injections with a small needle just under the skin of the stomach.